Study of the Relationship Between the Oxygenation State and Lung Ultrasound Score in Cardiac Surgery
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jul 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how well lung ultrasound can help assess the condition of patients' lungs after heart surgery. The researchers want to see if changes in a specific lung ultrasound score are related to improvements in oxygen levels in the blood, which is measured using a ratio called PaO2/FiO2. By understanding this relationship, the goal is to determine if lung ultrasound can be a useful tool for physiotherapists as they treat patients who need breathing support after surgery.
To participate in this study, you need to be at least 18 years old, have undergone heart surgery with the use of a heart-lung machine, and be able to provide informed consent. You should also have a manageable level of pain and be alert and oriented. If you join the trial, you can expect to undergo lung ultrasound and receive physiotherapy combined with non-invasive ventilation, which helps support your breathing. This study is currently recruiting participants, and you can choose to withdraw at any time without affecting your care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person having received complete information on the organization of the research and having given written consent to participate
- • Person having benefited from a heart surgery under cardio-pulmonary bypass
- • Medical prescriptions for non invasive ventilation and physiotherapist
- • Age ≥ 18 years
- • 18.5 ≤ BMI ≤ 35 kg/m2
- • Visual Analogy Scale pain \< 4
- • Patient conscious and oriented: Glasgow 15/15
- Exclusion Criteria:
- • At the patient's request : a patient may withdraw from the research at any time without affecting the quality of care to which he or she is entitled (withdrawal of consent).
- • Cardiorespiratory arrest during the inclusion visit.
- • Need for orotracheal reintubation during the inclusion visit.
- • Patient non-cooperation during the inclusion visit.
- • Failure of the ultrasound machine during the inclusion visit.
- • Failure of the blood gas analyzer.
- • Glasgow \< 15 during the inclusion visit
- • PEEP \> 6 cmH2O required during physiotherapy + non invasive ventilation session
- • PEEP \< 6 cmH2O required during physiotherapy + non invasive ventilation session
- • Premature interruption of the physiotherapy session + non invasive ventilation not hemodynamically tolerated
- • Need for a session of non invasive ventilation + physiotherapy \> 30 minutes.
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vandœuvre Lès Nancy, , France
Patients applied
Trial Officials
Jean PAYSANT
Study Director
Central Hospital, Nancy, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials